New York, June 12, 2026, 06:28 (ET)
- Rocket Lab is set to be added to the Nasdaq-100 index ahead of the open on June 22.
- RKLB ended Thursday at $114.78, up 9.26%. The stock was quoted higher again in early Friday after-hours trading.
- Index-fund buying tied to June 22, the upcoming Electron mission, and any news on Neutron’s first flight later this year are the main things to watch now.
Rocket Lab shares are in play after Nasdaq said the company will join the Nasdaq-100 Index before the open on Monday, June 22, in its regular June rebalance. The Nasdaq-100 tracks 100 of the biggest non-financial names on the exchange. Index trackers and ETFs usually buy new entrants to keep up. According to Nasdaq, products linked to the index account for over $800 billion worldwide.
RKLB ended Thursday’s regular session at $114.78, up $9.73, or 9.26%, MarketBeat data showed. The stock traded as high as $122.98 in extended hours as of 6:08 a.m. Eastern Friday. According to Investing.com, Rocket Lab jumped after hours after the Nasdaq-100 move, along with Astera Labs, CoreWeave, Nebius and Teradyne, which are also joining.
Rocket Lab’s stock move makes sense—getting added to an index can mean more liquidity, better visibility and buy orders from passive funds. These funds just track the index instead of picking stocks. For Rocket Lab, a growth name, the news means it’s not just seen as a speculative punt anymore but as a company now showing up in big-cap benchmarks on institutional screens.
Rocket Lab’s rally follows a strong Q1 report with record revenue at $200.3 million, up 63.5% from a year ago. Backlog hit $2.2 billion, up 20.2% from the previous quarter. Backlog is contracted business not yet counted as revenue. The company said it signed 31 new launch contracts for Electron and HASTE in the quarter, and five for dedicated Neutron launches. That lifts its launch manifest to more than 70 contracted missions.
Rocket Lab CEO Peter Beck told investors in the May results that “Rocket Lab’s tailwinds are strong.” The company gave revenue guidance for the second quarter of $225 million to $240 million and sees an adjusted EBITDA loss of $20 million to $26 million. Adjusted EBITDA—earnings before interest, taxes, depreciation and amortization, adjusted for some items—is a measure investors watch to gauge operating performance, but it’s not net profit. Benzinga
Investors are eyeing the June 22 Nasdaq-100 effective date, which could drive more index buying and heavier trading. Rocket Lab’s schedule puts the “Ten Owl Of Ten” Electron mission for Synspective on or after June 17, and another Electron launch for iQPS also in June. The company’s bigger operational move is still Neutron, its medium-lift reusable rocket. Rocket Lab says Neutron’s first launch is set for later this year. Rocket Lab
Rocket Lab now has three points bulls lean on: faster revenue growth, a big backlog, and demand from commercial, defense and national-security customers. Its move into the Nasdaq-100 could draw in more institutional investors as the company expands from Electron to space systems, hypersonics and Neutron. Bears point to valuation and the risk of not delivering. MarketBeat pegs Rocket Lab’s market cap at about $66.43 billion, with a price-to-sales ratio of 110.38. The consensus analyst price target is $99.24, about 13.5% under Thursday’s close. Price-to-sales shows how much investors are betting on growth versus current revenue; high numbers mean a hefty bet.
RKLB is looking risky at today’s price, even with momentum picking up. The stock already bakes in plenty of positives. The company isn’t profitable on a net-income basis, and it is still forecasting an adjusted EBITDA loss for Q2. RKLB also needs to ramp up launches and deliver on Neutron. Chasing the Nasdaq-100 rally here means betting that index demand, backlog converting, and rocket progress can counterbalance the valuation and possible delays.
